Newsfeeds - Spark Newswire

6 minute read

The Daily Biotech Pulse: Acorda Spikes On Distribution Deal, Alzamend Soars On Data, Pfizer-BioNTech To Supply More Vaccine Doses, 3 IPOs

Today, 10:04 PM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 22)

ACOR

5 minute read

The Daily Biotech Pulse: Sanofi Bets Big On mRNA Tech, Decision Day For MediWound, DiaMedica Issues Kidney Disease Data Readout

By Shanthi Rexaline

Today, 10:04 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 28)

ABUS

1 minute read

Horizon Acquires Rights to Arrowhead’s RNAi-Based Gout Treatment Candidate

By Vandana Singh

Today, 10:04 PM

Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) and Horizon Therapeutics plc (NASDAQ:HZNP) have entered into a global collaboration and license agreement for ARO-XDH for uncontrolled gout.…

ARWR

2 minute read

Horizon Therapeutics Announces Multiple Presentations On Neuromyelitis Optica Spectrum Disorder At the 7th Congress Of European Academy of Neurology

By Benzinga Newsdesk

Today, 10:04 PM

Horizon Therapeutics plc (NASDAQ:HZNP) today announced the presentation of company information on Neuromyelitis Optica Spectrum Disorder (NMOSD) in three oral sessions during the 7th Congress of the European Academy of

HZNP

1 minute read

OPKO Health Offloads Fill and Finish Manufacturing Facility in Ireland To Horizon Therapeutics

By Vandana Singh

Today, 10:04 PM

OPKO Health Inc’s (NASDAQ:OPK) subsidiary, EirGen Pharma Ltd, has agreed to sell one of its facilities in Waterford, Ireland, to Horizon Therapeutics…

HZNP

1 minute read

OPKO Health Announces SaleOf iIs Sterile Fill And Finish Manufacturing Facility In Ireland To Horizon Therapeutics For $65M

By Bill Haddad

Today, 10:04 PM

OPKO Health, Inc. (NASDAQ:OPK) announces that its subsidiary, EirGen Pharma, Ltd., has entered into a definitive agreement to sell one of its facilities in Waterford, Ireland to Horizon Therapeutics plc

HZNP